Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies

Epidemiology and Infection

Volumn 138, Issue 12, 2010, Pages 1804-1810

  Wong, A ^a   Marrie, T J ^a   Garg, S ^b   Kellner, J D ^c   Tyrrell, G J ^d,e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

Author keywords

Invasive pneumococcal disease; Malignancy; Pneumococcus; Serotype; Vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CANADA; CANCER REGISTRY; CHRONIC LYMPHATIC LEUKEMIA; DEMOGRAPHY; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INFECTION RISK; INVASIVE PNEUMOCOCCAL DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PNEUMOCOCCAL INFECTION; PREVALENCE; RETROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; INCIDENCE; MIDDLE AGED; NEOPLASM; RISK ASSESSMENT; SEROTYPING;

ADULT; AGED; AGED, 80 AND OVER; ALBERTA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 78149252030     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810000919     Document Type: Article

References (21)

1. Yu VL, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clinical Infectious Diseases 2003; 37: 230-237.
2. Schuchat A, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. New England Journal of Medicine 1997; 337: 970-976.
3. Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1997; 46: 1.
4. Dworkin MS, et al. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clinical Infectious Diseases 2001; 32: 794-800. (Pubitemid 32221939)
5. Moberley SA, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews 2008; Issue No. 1. Art. No. CD000422.
6. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedules - United States, 2008. Morbidity and Mortality Weekly Report 2007; 56: 1.
7. Public Health Agency of Canada. Pneumococcal vaccine. In: Canadian Immunization Guide, 7th edn. Ottawa: Public Health Agency of Canada, 2006, pp. 267-276.
8. Kyaw MH, et al. Adults with invasive pneumococcal disease: missed opportunities for vaccination. American Journal of Preventive Medicine 2006; 31: 286-292. (Pubitemid 44354003)
9. Kyaw MH, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. Journal of Infectious Diseases 2005; 192: 377-386. (Pubitemid 41023115)
10. Kyaw MH, et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clinical Infectious Diseases 2003; 37: 1283-1291.
11. Hjuler T, et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008; 122: e26-32.
12. Alberta Health and Wellness (AH&W). Population Projections for Alberta and its Health Regions, 2000-2030. Edmonton: AH&W, 2001.
13. Health Canada. Case definitions for diseases under national surveillance. Canadian Communicable Disease Report 2000; 26: S3-S51.
14. Wang M. Surveillance analyst, Alberta Cancer Board, personal communication, 21 February 2008.
15. Facklam RR, Washington JA. Streptococcus and related catalase-negative gram-positive cocci. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology, 5th edn. Washington, DC: American Society for Microbiology, 1991, pp. 238-257.
16. Lund R, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris JR, eds. Methods in Microbiology, vol. 12. New York: Academic Press Inc., 1978, pp. 241-262.
17. Meisel R, et al. Increased risk for invasive pneumococcal disease in children with acute lymphoblastic leukaemia. British Journal of Haematology 2007; 137: 457-460. (Pubitemid 46698293)
18. Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. European Journal of Haematology 1993; 51: 102-108. (Pubitemid 23287812)
19. Jacobson DR, Zolla-Pazner S. Immunosuppression and infection in multiple myeloma. Seminars in Oncology 1986; 13: 282-290. (Pubitemid 17204706)
20. Pilarski LM, et al. Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma. Scandinavian Journal of Immunology 1989; 29: 217-228. (Pubitemid 19068591)
21. Musher DM. Pneumococcal vaccine - direct and indirect (herd) effects. New England Journal of Medicine 2006; 354: 1522-1524.